Quote from: ElmetElmet on October 18, 2017, 10:18:47 AM

Quote from: Zenome Platform on October 17, 2017, 03:45:55 PM

Quote from: ElmetElmet on October 17, 2017, 11:57:55 AM

Impressive project, much needed. I have read the whitepaper, very long and detailed (a bit hard to understand, though). You think you will have a good share of predicted $60 Billion market for genomic technologies in 2020?

We think that we can claim a large part of the market, because our platform will be an infrastructure for the market.

"Zenome DNA (ZNA) is an utility token on Zenome platform. The valuation of ZNA is tied to the success of the platform."

Is it possible that your share of the market will be related to the value of the tokens? I think this is important question and prospective investors would like to know that before taking part in ICO.

When the critical size of the genomic database is reached, we begin to sell data to large companies from Big Pharma, FMCG, state structures and e-commerce companies such as Google, Alibaba and Facebook with Amazon. According to our estimates, our genetic database will contain 1 million genomes by the end of 2018. After having collected anticipated amount of genetic data in our database, we are going to allow users to exchange genetic data. In short, at that time we will begin the monetization of genetic data. After having collected anticipated amount of genetic data, the ZNA token price will increase.
The market for the personal genomic data purchasing by various companies is still difficult to assess, since it is in its infancy. To date, the total aggregate of transactions doesn't exceed $ 200 million, but we are confident that in the next 5-10 years this market will be one of the largest in the world.